FibroGen Inc (FGEN)
0.3699
+0.04
(+11.89%)
USD |
NASDAQ |
Nov 14, 16:00
0.38
+0.01
(+2.73%)
After-Hours: 20:00
FibroGen Gross Profit (Annual): 128.90M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 128.90M |
| December 31, 2022 | 120.45M |
| December 31, 2021 | 222.44M |
| December 31, 2020 | 167.45M |
| Date | Value |
|---|---|
| December 31, 2019 | 255.43M |
| December 31, 2018 | 212.96M |
| December 31, 2017 | 131.00M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
120.45M
Minimum
2022
255.43M
Maximum
2019
178.94M
Average
167.45M
Median
2020
Gross Profit (Annual) Benchmarks
| Biomarin Pharmaceutical Inc | 1.904B |
| Arbutus Biopharma Corp | -- |
| GlycoMimetics Inc | -- |
| Cidara Therapeutics Inc | 62.38M |
| Cue Biopharma Inc | -- |